We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BioVendor Group

BioVendor Group is an international group of biotechnology companies (BioVendor LM, BioVendor R&D, TestLine, ViennaLa... read more Featured Products: More products

Download Mobile App





BioVendor Presents Its Portfolio of IVD Products and Technologies for Lab Automation

By LabMedica International staff writers
Posted on 26 Apr 2022
Print article
Image: KleeYa fully automated CLIA solution (Photo courtesy of BioVendor Group)
Image: KleeYa fully automated CLIA solution (Photo courtesy of BioVendor Group)

BioVendor Group (Brno, Czech Republic) celebrated its 30th anniversary by presenting its key product portfolio, including CLIA, NGS, Microblot Array, microRNA and LAMP products, at ECCMID 2022.

In the NGS field, BioVendor showcased its new technology fastGEN for examination of the mutation status of oncomarkers in samples. The technology is based on ultra-deep sequencing of short amplicons obtained by a single polymerase chain reaction with special tagged hybrid primers. The company presented its user-friendly diagnostic kits with software solution for KRAS, NRAS, BRAF, EGFR and IDH 1/2 genes with excellent analytical parameters and fast processing. BioVendor demonstrated its GENOVESA software fastGEN module, a cloud all-in-one solution for the analysis of raw data (FASTQ files) with technical and application support.

Among its solutions for multiplex diagnostics, BioVendor presented Microblot-Array (MBA), a new generation of a market-unique immunoblot array in a microtiter plate format. MBA is designed for efficient multiplex diagnostics, enabling the simultaneous detection of multiple markers which is time and cost-saving. The technology eliminates the limited capacity of traditional BLOT strips and opens the way to high throughput testing. Simple processing can be done manually or automatically using any open ELISA analyzers. The comprehensive evaluation is ensured by the TestLine Reader and Software (SW) for complex image analysis, including results evaluation and connectivity to LIS. BioVendor also showcased its LAMP Assays for the direct detection of target nucleic acids without the need of the isolation step. The unique architecture of the LAMP method ensures its high sensitivity and specificity and a tolerance for inhibitory substances

BioVendor provided a virtual tour of its KleeYa automated CLIA analyzer that offers an attractive portfolio of innovative and established diagnostic parameters and provides a comprehensive chemiluminescence system for diagnostic laboratories. With a graphical user interface, users can learn to control the fully automated system in minutes. KleeYa software is designed to minimize the burden on laboratory staff. Thanks to augmented reality, technical support is available to users at any time, right in the lab with advise on operation, settings and minor service tasks.

Related Links:
BioVendor Group

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Vaginitis Test
Allplex Vaginitis Screening Assay
New
HIV-1 Test
HIV-1 Real Time RT-PCR Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The study demonstrated that electric-field molecular fingerprinting can probe cancer (Photo courtesy of ACS Central Science, 2025, 10.1021/acscentsci.4c02164)

New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma

Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more

Molecular Diagnostics

view channel
Image: The test can find tRNA fragments unique to Parkinson’s disease before patients even have symptoms (Photo courtesy of Shutterstock)

Rapid Blood Test Identifies Pre-Symptomatic Patients with Parkinson’s Disease

Currently, no reliable blood test exists for diagnosing Parkinson’s disease. Instead, physicians rely on observing a patient's movements, but this qualitative method has an error rate of 20%-25% and can... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.